Efficacy of intramuscular matrine in the treatment of chronic hepatitis B

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 1, 2004, Pages 69-72

  Long, Yao ^a   Lin, Xiao Tian ^b   Zeng, Kun Lun ^c   Zhang, Lian ^c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Haibin Centre Hospital   (China)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B therapy; HBV DNA; Hepatitis B surface antigen; Hepatitis Be antigen; Matrine therapeutical effect; Seroconversion

Indexed keywords

GLUCURONOLACTONE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HERBACEOUS AGENT; INOSINE DERIVATIVE; MATRINE; OLEANOLIC ACID; PLANT EXTRACT; PROTECTIVE AGENT; SOPHORA FLAVESCENS EXTRACT; VIRUS DNA; VITAMIN B GROUP;

ARTICLE; BIOCHEMISTRY; CHINESE HERB; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; INJECTION PAIN; INTERMETHOD COMPARISON; LEUKOPENIA; LIVER FUNCTION; LIVER PROTECTION; MAJOR CLINICAL STUDY; SIDE EFFECT; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; INJECTIONS, INTRAMUSCULAR; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; QUINOLIZINES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 1342287277     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hu ZL, Zhang JP, Wan MB, Yu XB, Lin W, Qian DH. Effect of matrine on mouse hepatitis and tumor necrosis factor production induced by Propionibacterium acnes/lipopolysaccharides. Yao Xue Xue Bao 1996;31:662-665.
2. Hu ZL, Zhang JP, Yu XB, Lin W, Qian DH, Wan MB. Effect of matrine on lipopolysaccharides/D-galactosamine-induced hepatitis and tumor necrosis factor release from macrophages in vitro. Zhongguo Yao Li Xue Bao 1996;17:351-353.
3. Lin W, Zhang JP, Hu ZL, Qian DH. Inhibitory effect of matrine on lipopolysacchride-induced tumor necrosis factor and interleukin-6 production from rat Kupffer cells. Yao Xue Xue Bao 1997;32:93-96.
4. Liu AP, Pang XY, Gu YN, Wang KL, Xun CP. Clinical observation of matrine for antifibrosis. Chin J Integrated Trad West Med Liver Dis 2001;11:71-72.
5. Gan LW, Wang GJ, Li YL. Effect of oxymatrine on hepatic fibrosis in rat. Acad J Second Military Med Univ 1999;20:445-448.
6. Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou B, Xie WF, et al. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin 2001;22:183-186.
7. Zhang JP, Zhang M, Jin C, Zhou B, Xie WF, Guo C, et al. Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin 2001;22:765-768.
8. Tang ZM, Peng M, Zhan CJ. Screening 20 Chinese herbs often used for clearing heat and dissipating toxin with nude mice model of hepatitis C viral infection. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003;23:447-448.
9. Liu J, Zhu M, Shi R, Yang M. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med 2003;31:337-354.
10. Li JQ, Chen X, Zeng MD, Lu LG, Qiu DK, Mao YM, et al. The inhibitory effect of oxymatrine on hepatitis B virus in vitro. Chin J Digest 2001;21:550-552.
11. Jiang XJ, Bao JF. The therapeutic evaluation of oxymatrine in the treatment of chronic hepatitis B. Chin J Gastroenterol Hepatol 2001;10:191.
12. Xing SH, Shen MW, Ma ZX. Preliminary observation of effects of matrine orally on hepatic injury experimentally and clinically. Pharmacol Clin Chin Materia Med 1998;14:42-44.
13. Li JQ, Li CQ, Zeng MD, She XK, Li GQ, Fan JG, et al. Preliminary study of oxymatrine in treatment of chronic hepatitis C. J Integrated Trad West Med 1998;18:227-229.
14. Li JY. Matrine for treatment of 31 patients with chronic hepatitis B. Shaanxi J Trad Chin Med 1991;11:389-390.
15. Cai X, Wang GJ, Zai Y, Fan CH, Zhang RQ, Xu WS. Analysis of efficacy of matrine injection in treatment of chronic hepatitis B. Acad J Second Military Med Univ 1997;18:47-49.
16. Bai SS, Li XX, Zheng WY, Xu X, Guo HZ. Primary observation on efficacy of matrine in the treatment of chronic hepatitis B. Inner Mongolia Med J 1998;30:266-267.
17. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34:1225-1241.
18. Manns MP. Current state of interferon therapy in the treatment of chronic hepatitis B. Semin Liver Dis 2002;22( Suppl 1):7-13.
19. Marcellin P. Advances in therapy for chronic hepatitis B. Semin Liver Dis 2002;22 Suppl 1:33-36.
20. Wai CT, Lok AS. Treatment of hepatitis B. J Gastroenterol 2002;37:771-778.
21. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, et al. Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 2000;32:828-834.
22. Feld J, Locarnini S. Antiviral therapy for hepatitis B virus infectious: new targets and technical challenges. J Clin Virol 2002;25:267-283.
23. Akuta N, Suzuki F, Kobayashi M, Matsuda M, Sato J, Takagi K, et al. Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy. Med Virol 2003;71:504-510.
24. Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003;36:687-696.
25. Fontaine H, Pol S. Side effects of interferon-alpha in treating hepatitis C virus infection. Transplant Proc 2001;33:2327-2329.
26. Kerl K, Negro F, Lubbe J. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin. J Dermatol 2003;149:656.
27. Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003;37:443-451.
28. Iorio R, Pensati P, Botta S, Moschella S, Impagliazzo N, Vajro P, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997;16:984-990.
29. Feng YZ, Zhou R, Wei XF, Li JL, Jin YH, Cai FQ. Effects of Radix Sophorae Flavescentis on inhibition of immune function in mice. Henan J Trad Chin Med Pharmacy 1997;17:277-278.
30. Wang JX, Wang GJ, Cai X, He P. Effect of oxymatrine and glycyrrhizin on hepatocellular apoptosis in mice. Acad J Second Military Med Univ 1999;20:222-224.